66 related articles for article (PubMed ID: 34129195)
1. miR-889-3p targeting BMPR2 promotes the development of retinoblastoma via JNK/MAPK/ERK signaling.
Gao Y; Du P
Sci Rep; 2024 Mar; 14(1):7277. PubMed ID: 38538669
[TBL] [Abstract][Full Text] [Related]
2. Quercetin suppresses retinoblastoma cell proliferation and invasion and facilitates oxidative stress-induced apoptosis through the miR-137/FNDC5 axis.
Ye Q; Zeng Z; Liang X; Li W
Environ Res; 2023 Nov; 237(Pt 2):116934. PubMed ID: 37598849
[TBL] [Abstract][Full Text] [Related]
3. Serum miR-338-5p has potential for use as a tumor marker for retinoblastoma.
Zhou P; Li X
Oncol Lett; 2019 Jul; 18(1):307-313. PubMed ID: 31289501
[TBL] [Abstract][Full Text] [Related]
4. Identification of miR-20a as A Potential Discerning Biomarker for Non-Invasive versus Invasive Retinoblastoma.
Bereimipour A; Karimi S; Faranoush M; Hedayati Asl AA; Miri MS; Satarian L; Taleahmad S
Cell J; 2024 May; 26(4):250-258. PubMed ID: 38736409
[TBL] [Abstract][Full Text] [Related]
5. Role of non-coding RNAs and exosomal non-coding RNAs in retinoblastoma progression.
Ahangar Davoodi N; Najafi S; Naderi Ghale-Noie Z; Piranviseh A; Mollazadeh S; Ahmadi Asouri S; Asemi Z; Morshedi M; Tamehri Zadeh SS; Hamblin MR; Sheida A; Mirzaei H
Front Cell Dev Biol; 2022; 10():1065837. PubMed ID: 36619866
[TBL] [Abstract][Full Text] [Related]
6. Diverse MicroRNAs-mRNA networks regulate the priming phase of mouse liver regeneration and of direct hyperplasia.
Pal R; Kowalik MA; Serra M; Migliore C; Giordano S; Columbano A; Perra A
Cell Prolif; 2022 Apr; 55(4):e13199. PubMed ID: 35174557
[TBL] [Abstract][Full Text] [Related]
7. MiR-132 promotes the proliferation, invasion and migration of human pancreatic carcinoma by inhibition of the tumor suppressor gene PTEN.
Zhang H; Liu A; Feng X; Tian L; Bo W; Wang H; Hu Y
Prog Biophys Mol Biol; 2019 Nov; 148():65-72. PubMed ID: 28941804
[TBL] [Abstract][Full Text] [Related]
8. Advancements in the diagnosis, prognosis, and treatment of retinoblastoma.
Rajput S; Malviya R; Uniyal P
Can J Ophthalmol; 2024 Feb; ():. PubMed ID: 38369298
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-9 inhibits proliferation and progression in retinoblastoma cells by targeting PTEN.
Gao M; Cui Z; Zhao D; Zhang S; Cai Q
Genes Genomics; 2021 Sep; 43(9):1023-1033. PubMed ID: 34129195
[TBL] [Abstract][Full Text] [Related]
10. MiR-142-5p promotes retinoblastoma cell proliferation, migration and invasion by targeting PTEN.
Zhang Y; Zheng A
J Biochem; 2021 Oct; 170(2):195-202. PubMed ID: 34562091
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of miR-204-3p Driven by the Viability and Motility of Retinoblastoma via Wnt/β-catenin Pathway In Vitro and In Vivo.
Sun QX; Wang RR; Liu N; Liu C
Pathol Oncol Res; 2020 Jul; 26(3):1549-1558. PubMed ID: 31482398
[TBL] [Abstract][Full Text] [Related]
12. MiR-21 inhibitor suppressed the progression of retinoblastoma via the modulation of PTEN/PI3K/AKT pathway.
Gui F; Hong Z; You Z; Wu H; Zhang Y
Cell Biol Int; 2016 Dec; 40(12):1294-1302. PubMed ID: 27600360
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-129-5p suppresses proliferation, migration and invasion of retinoblastoma cells through PI3K/AKT signaling pathway by targeting PAX6.
Liu Y; Liang G; Wang H; Liu Z
Pathol Res Pract; 2019 Dec; 215(12):152641. PubMed ID: 31727502
[TBL] [Abstract][Full Text] [Related]
14. Circular RNA circ-FAM158A promotes retinoblastoma progression by regulating miR-138-5p/SLC7A5 axis.
Zheng T; Chen W; Wang X; Cai W; Wu F; Lin C
Exp Eye Res; 2021 Oct; 211():108650. PubMed ID: 34102206
[TBL] [Abstract][Full Text] [Related]
15. miR-149-3p Regulates the Switch between Adipogenic and Osteogenic Differentiation of BMSCs by Targeting FTO.
Li Y; Yang F; Gao M; Gong R; Jin M; Liu T; Sun Y; Fu Y; Huang Q; Zhang W; Liu S; Yu M; Yan G; Feng C; He M; Zhang L; Ding F; Ma W; Bi Z; Xu C; Yuan Y; Cai B; Yang L
Mol Ther Nucleic Acids; 2019 Sep; 17():590-600. PubMed ID: 31382190
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
